Cargando…

Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains

Parkinson’s disease (PD) and dementia with Lewy body (DLB) are the most common synucleinopathies. SNCA gene is a major genetic risk factor for these diseases group, and dysregulation of its expression has been implicated in the genetic etiologies of several synucleinopathies. DNA methylation at CpG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Jeffrey, Barrera, Julio, Yun, Young, Murphy, Susan K., Beach, Thomas G., Woltjer, Randy L., Serrano, Geidy E., Kantor, Boris, Chiba-Falek, Ornit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113398/ https://www.ncbi.nlm.nih.gov/pubmed/33994928 http://dx.doi.org/10.3389/fnins.2021.652226

Ejemplares similares

The Landscape of SNCA Transcripts Across Synucleinopathies: New Insights From Long Reads Sequencing Analysis
por: Tseng, Elizabeth, et al.
Publicado: (2019)

Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168
por: Glenn, Omolara-Chinue, et al.
Publicado: (2017)

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s
por: Yang, Anna, et al.
Publicado: (2021)

Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer’s disease
por: Angrist, Misha, et al.
Publicado: (2020)

Probing the role of PPARγ in the regulation of late-onset Alzheimer’s disease-associated genes
por: Barrera, Julio, et al.
Publicado: (2018)

Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases
por: Rittiner, Joseph Edward, et al.
Publicado: (2020)

Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy
por: Mohamed, Nguyen-Vi, et al.
Publicado: (2021)

Shared genetic etiology underlying Alzheimer’s disease and major depressive disorder
por: Lutz, Michael W., et al.
Publicado: (2020)

Engineering synucleinopathy‐resistant human dopaminergic neurons by CRISPR‐mediated deletion of the SNCA gene
por: Chen, Yixi, et al.
Publicado: (2018)

New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy
por: Yang, Yang, et al.
Publicado: (2023)

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain
por: Cronin, Kenneth D., et al.
Publicado: (2009)

Differential Gene Expression and DNA Methylation in the Risk of Depression in LOAD Patients
por: Upadhya, Suraj, et al.
Publicado: (2022)

Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
por: Gamache, Julia, et al.
Publicado: (2020)

Bioinformatics pipeline to guide late‐onset Alzheimer's disease (LOAD) post‐GWAS studies: Prioritizing transcription regulatory variants within LOAD‐associated regions
por: Lutz, Michael W., et al.
Publicado: (2022)

Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing
por: Perez-Rodriguez, Diego, et al.
Publicado: (2019)

Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020)

Intronic enhancers of the human SNCA gene predominantly regulate its expression in brain in vivo
por: Cheng, Fubo, et al.
Publicado: (2022)

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?
por: Kiely, Aoife P., et al.
Publicado: (2013)

Gene Expression Analysis of Neurons and Astrocytes Isolated by Laser Capture Microdissection from Frozen Human Brain Tissues
por: Tagliafierro, Lidia, et al.
Publicado: (2016)

The cis-Regulatory Element of SNCA Intron 4 Modulates Susceptibility to Parkinson’s Disease in Han Chinese
por: Zhu, Shi-Guo, et al.
Publicado: (2020)

The Role of Upregulated APOE in Alzheimer’s Disease Etiology
por: Gottschalk, William K, et al.
Publicado: (2016)

Prognostic significance of SNCA and its methylation in bladder cancer
por: Wu, Zhengcun, et al.
Publicado: (2022)

A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies
por: Hartlage-Rübsamen, Maike, et al.
Publicado: (2021)

Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body disease
por: Serrano, Geidy E, et al.
Publicado: (2020)

Polygenic Risk Score Effectively Predicts Depression Onset in Alzheimer’s Disease Based on Major Depressive Disorder Risk Variants
por: Upadhya, Suraj, et al.
Publicado: (2022)

SNCA Gene Methylation in Parkinson’s Disease and Multiple System Atrophy
por: Fedotova, Ekaterina Yu., et al.
Publicado: (2023)

Integrative single-nucleus multi-omics analysis prioritizes candidate cis and trans regulatory networks and their target genes in Alzheimer’s disease brains
por: Gamache, Julia, et al.
Publicado: (2023)

Detection of SNCA and FBN1 Methylation in the Stool as a Biomarker for Colorectal Cancer
por: Li, Wen-han, et al.
Publicado: (2015)

SNCA-AS1 in aging and Parkinson’s disease
por: Carelli, Stephana, et al.
Publicado: (2022)

Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study
por: Chiba-Falek, Ornit, et al.
Publicado: (2010)

Sex dependent glial-specific changes in the chromatin accessibility landscape in late-onset Alzheimer’s disease brains
por: Barrera, Julio, et al.
Publicado: (2021)

Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies
por: Corbillé, Anne-Gaëlle, et al.
Publicado: (2016)

Chemical disaggregation of alpha-synuclein fibrils as a therapy for synucleinopathies
por: Wu, Shenjie, et al.
Publicado: (2023)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
por: Kiely, Aoife P., et al.
Publicado: (2015)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
por: Li, Yuanyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hkaesfrltbsm4a99gpe94hmmc0